 |
Acorda Therapeutics
ACOR
|
48.3 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Adverum Biotechnologies
ADVM
|
222 |
- |
- |
$ 86.2 M |
USA |
 |
Amgen
AMGN
|
81.2 |
$ 340.0 |
-0.75 % |
$ 183 B |
USA |
 |
Amneal Pharmaceuticals
AMRX
|
55.7 |
$ 12.32 |
-0.24 % |
$ 3.86 B |
USA |
 |
I-Mab
IMAB
|
271 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 |
- |
- |
$ 40.3 B |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
106 |
$ 23.27 |
-1.63 % |
$ 2.96 B |
USA |
 |
Autolus Therapeutics plc
AUTL
|
58.2 |
$ 1.36 |
-2.16 % |
$ 362 M |
Britain |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 |
- |
- |
$ 7.46 M |
Israel |
 |
Midatech Pharma plc
MTP
|
204 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
52.6 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Alterity Therapeutics Limited
ATHE
|
16.2 K |
$ 3.76 |
4.35 % |
$ 9.05 B |
Australia |
 |
CymaBay Therapeutics
CBAY
|
182 |
- |
- |
$ 3.45 B |
USA |
 |
Advaxis
ADXS
|
88.1 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Aytu BioScience
AYTU
|
150 |
$ 2.57 |
-3.38 % |
$ 16.1 M |
USA |
 |
Avid Bioservices
CDMO
|
45.6 |
- |
- |
$ 789 M |
USA |
 |
Cidara Therapeutics
CDTX
|
2.26 K |
- |
- |
$ 1.41 B |
USA |
 |
Checkpoint Therapeutics
CKPT
|
6.83 |
- |
- |
$ 169 M |
USA |
 |
Aeterna Zentaris
AEZS
|
146 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
186 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Concert Pharmaceuticals
CNCE
|
147 |
- |
- |
$ 401 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 |
- |
- |
$ 1.01 B |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.114 |
- |
- |
$ 26.5 M |
USA |
 |
CTI BioPharma Corp.
CTIC
|
52.1 |
- |
- |
$ 1.2 B |
USA |
 |
AIkido Pharma
AIKI
|
17.9 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
3.66 K |
- |
-4.36 % |
$ 27 M |
USA |
 |
Cyclerion Therapeutics
CYCN
|
120 |
$ 3.48 |
-16.14 % |
$ 8.76 M |
USA |
 |
Deciphera Pharmaceuticals
DCPH
|
60.8 |
- |
- |
$ 2.18 B |
USA |
 |
Dynavax Technologies Corporation
DVAX
|
56.5 |
- |
- |
$ 2.02 B |
USA |
 |
CureVac N.V.
CVAC
|
13.6 |
- |
- |
$ 867 M |
Germany |
 |
Dyadic International
DYAI
|
78.4 |
$ 0.88 |
1.66 % |
$ 31.8 M |
USA |
 |
Coherus BioSciences
CHRS
|
559 |
$ 1.67 |
- |
$ 196 M |
USA |